Banner News

Taiwan, January 7, 2022 –For all diagnostic procedures to test COVID-19, performing these tests at POC or near-POC requires a suitable and sufficient risk assessment and implementation of appropriate control measures. It is essential that the rapid testing procedure, which may involve swab stirring/mixing into an elution buffer with the potential for associated generation of aerosols, does not place individuals performing these tests at an increased risk of SARS-CoV-2 exposure. It is therefore highly desirable that rapid testing procedures include a step that reduces the titer of infectious virus presents, e.g., by eluting samples into an effective lysis buffer.

In a study to assess the inactivation effectiveness of sampling buffers used, the UK National Infection Service (NIS) laboratories recently published in the Nature Scientific Reports to demonstrated the VitaPCR™ sample collection buffer is able to inactivate SARS-CoV-2 effectively, which provides clinicians in the front line with sufficient protection against SARS-CoV-2.

According to the study results, a >5.0 log10 reduction in SARS-CoV-2 titer was confirmed after one-minute treatment with VitaPCR™ sample collection buffer, which went up to 6.2 log10 reduction after a five-minute mixing. Data presented in this study showed the capability of VitaPCR™ sample collection buffer to ensure the protection of test operators, which also meets the requirement of the British European standard BS EN 14476 for effectiveness against viruses.

VitaPCR™ sample collection buffer, the next-generation (guanidine-free) nucleic acid extraction buffer, not only inactivates SARS-CoV-2 during contact but also eliminates the chemical hazards associated with conventional guanidine-based reagents in diagnostic procedures.

For more information, please refer to or contact us at:

About Credo Diagnostics Biomedical Pte. Ltd.

Credo Diagnostics develops and manufactures innovative, easy-to-use and rapid molecular diagnostic solutions for Point-of-Care (POC) applications at affordable costs without compromising accuracy and speed in the areas Human Health. Leveraging solid and established science, combined with efficient integration and strategic innovation, Credo Diagnostics Biomedical provides advanced medical technologies for all.



We at Credo Diagnostics pioneer accessible diagnostic platforms to improve the lives of those we love. We believe providing the right information to the right people at the right time leads to better outcomes.